Emmaus Life Sciences Submits New Drug Application for Sickle Cell Disease Treatment Sep 08, 2016 8:00am EDT
Emmaus Life Sciences to Seek Marketing Approval for First New Sickle Cell Disease Treatment in Nearly 20 Years; Expects to Submit New Drug Application to FDA in September Aug 22, 2016 8:00am EDT
Emmaus Life Sciences Secures Funding to Advance Sickle Cell Disease Treatment Jan 26, 2016 8:00am EST
Emmaus Life Sciences to Present Additional New Data from its Phase 3 Sickle Cell Disease Trial at 57th Annual ASH Meeting Dec 02, 2015 8:30am EST
Emmaus Life Sciences to Present at Maxim Group's Sickle Cell Disease Investor Conference on November 20 Nov 20, 2015 11:10am EST
Emmaus Life Sciences to Present at Upcoming Investor and Partnering Conferences During National Sickle Cell Awareness Month Sep 01, 2015 8:00am EDT
